MOLECULAR TEMPLATES INC (MTEM)

Company Profile

Molecular Templates Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Austin, Texas and currently employs 222 full-time employees. The company went IPO on 2005-02-04. Molecular Templates, Inc. is a clinical-stage biopharmaceutical company. The firm is focused on the discovery and development of targeted biologic therapeutics. Its drug platform technology, known as engineered toxin bodies (ETBs), leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer. Its product pipeline includes MT-6402, MT-8421 and MT-0169. MT-6402 is an ETB consisting of a single chain variable fragment (scFv), with affinity for PD-L1, fused to the enzymatically active de-immunized Shiga-like toxin-A subunit (SLTA) and a class I antigen derived from the human cytomegalovirus (HCMV). pp65 protein. MT-8421, its ETB targeting CTLA-4, along with MT-6402. MT-0169 focuses on targeting CD38. CD38 is a single-chain type II transmembrane glycoprotein that is expressed by a variety of hematologic cells in an activation- and differentiation-dependent manner.

Company Info

MOLECULAR TEMPLATES INC

9301 Amberglen Blvd Ste 100

Austin TEXAS 78729

P: 15128961555

CEO: Eric E. Poma

Employees: 222

Website: https://mtem.com/